Zhisheng Liu Junling Zhang Yunjie Ge Mengli Huang Ye Wang
10.2147/CMAR.S397711
Cancer Manag Res
2023 Feb 22;15:197-201.
lusc pd-1 inhibitor c-sclc high tumor mutational burden
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/36860892/
Case Reports
PMC9968780
36860892
Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report
2023